N. Pescosolido, Vittorio Gatto, Alessio Stefanucci
Mar 1, 2015
Citations
1
Influential Citations
44
Citations
Quality indicators
Journal
Ophthalmic and Physiological Optics
Abstract
Agomelatine is an agonist of melatonin that is used in the treatment of major depressive disorders. It has also shown an ability to decrease IOP in experiment animals and in normal human subjects. This pilot study addresses for the first time agomelatine effects on the IOP of patients affected by POAG.